| Literature DB >> 28012245 |
Daisuke Tomizawa1,2, Akifumi Endo2, Michiko Kajiwara2, Hirotoshi Sakaguchi3, Kimikazu Matsumoto1,3, Makoto Kaneda4, Takashi Taga5.
Abstract
Patients with Down syndrome (DS) are predisposed to acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) in early and later childhood, respectively, but rarely experience both. We herein discuss four patients with DS with ALL and a history of AML who were treated with various chemotherapies, one of whom later received a bone marrow transplantation. Three patients survived and remain in remission. One patient died of fulminant hepatitis during therapy. No common cytogenetic abnormalities in AML and ALL besides constitutional +21 were identified, indicating that the two leukemia types were independent events. However, the underlying pathomechanism of these conditions awaits clarification.Entities:
Keywords: Down syndrome; acute lymphoblastic leukemia; acute myeloid leukemia
Mesh:
Year: 2016 PMID: 28012245 DOI: 10.1002/pbc.26411
Source DB: PubMed Journal: Pediatr Blood Cancer ISSN: 1545-5009 Impact factor: 3.167